2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1154344281 DMD
Verify on CMS →

ROSS SANFILIPPO, DMD

Oral and Maxillofacial Pathology Dentistry in NEW LONDON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
542
Medicare Part D claims · 290 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
What the federal data reveals: ROSS SANFILIPPO, DMD is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in NEW LONDON, Connecticut with a Medicare Part D prescribing footprint of 542 claims across 290 beneficiaries .

What stands out: ROSS SANFILIPPO, DMD filed 542 Medicare Part D claims in 2023 across NEW LONDON, Connecticut. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROSS SANFILIPPO, DMD at a glance

Quality data not reported

NPI registry status

Active

Issued 07/26/2006

NPI 1154344281

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

542 79% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in Connecticut

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among Connecticut providers

Connecticut providers

Oral and Maxillofacial Pathology Dentistry share within Connecticut

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROSS SANFILIPPO, DMD is a Oral and Maxillofacial Pathology Dentistry provider practicing in NEW LONDON, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DMD. NPI: 1154344281. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROSS SANFILIPPO, DMD appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding DMD credentials at 4 SHAWS CV, NEW LONDON, CT, 06320, with a listed phone of (860) 443-3619. NPI 1154344281 was issued on 07/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SANFILIPPO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 542 prescription claims written by this provider, covering 290 Medicare beneficiaries and totaling roughly $2K in drug spend, with an opioid prescribing rate of 14.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4 SHAWS CV
NEW LONDON, CT 06320

Provider Details

NPI 1154344281
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials DMD
Gender Male
NPI Issued 07/26/2006

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

542
Total Claims
$2K
Total Drug Cost
290
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
543
Total Day Supply
3,549
Generic Drug Cost
$2K
Opioid Claims
79 (14.6% rate)
Antibiotic Claims
341

Patient Demographics

Average Patient Age
75.5 years
Avg HCC Risk Score
1.31
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amoxicillin
264
Chlorhexidine Gluconate
68
Clindamycin Hcl
51
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
36
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
35
Dexamethasone
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How ROSS SANFILIPPO, DMD fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

ROSS SANFILIPPO, DMD's 542 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as SANFILIPPO.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROSS SANFILIPPO, DMD's specialty?
ROSS SANFILIPPO, DMD specializes in Oral and Maxillofacial Pathology Dentistry and practices in NEW LONDON, Connecticut. Credentials: DMD.
How much does ROSS SANFILIPPO, DMD prescribe under Medicare Part D?
In 2023, ROSS SANFILIPPO, DMD wrote 542 Medicare Part D claims totaling $2K in drug costs for 290 beneficiaries.
Where is ROSS SANFILIPPO, DMD located?
ROSS SANFILIPPO, DMD is located at 4 SHAWS CV, NEW LONDON, CT, 06320. Phone: (860) 443-3619.
What is ROSS SANFILIPPO, DMD's NPI number?
ROSS SANFILIPPO, DMD's National Provider Identifier (NPI) is 1154344281, issued on 07/26/2006.
Does ROSS SANFILIPPO, DMD prescribe opioids?
Yes, ROSS SANFILIPPO, DMD had 79 opioid claims in 2023 with an opioid prescribing rate of 14.6%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does ROSS SANFILIPPO, DMD prescribe most often?
Based on 2023 Medicare Part D data, ROSS SANFILIPPO, DMD's most frequently prescribed drugs include Amoxicillin, Chlorhexidine Gluconate, Clindamycin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROSS SANFILIPPO, DMD accept Medicare?
ROSS SANFILIPPO, DMD appears in CMS Medicare data with 542 Part D claims and 290 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROSS SANFILIPPO, DMD's credentials?
ROSS SANFILIPPO, DMD's NPI is 1154344281 with credentials DMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology